These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1934527)

  • 1. Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
    Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):129-35. PubMed ID: 1934527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
    Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
    J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
    Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
    Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
    Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term infusion of growth hormone (GH)-releasing factor on pulsatile GH secretion in the male rat.
    Sato M; Murao K; Niimi M; Tamaki M; Takahara J
    Life Sci; 1994; 54(2):79-86. PubMed ID: 8277821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME; Stein MB; Uhde TW
    Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha-methyl-p-tyrosine and an antiserum to rat growth hormone (GH)-releasing factor (GRF) on plasma GH secretory profile during a continuous infusion of human GRF in rats.
    Sugihara H; Wakabayashi I; Minami S; Takahashi F; Shibasaki T; Ling N
    Brain Res; 1988 Dec; 475(1):128-33. PubMed ID: 3145782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion of growth hormone-releasing factor: effects on pulsatile growth hormone secretion in normal rats.
    Wehrenberg WB
    Neuroendocrinology; 1986; 43(3):391-6. PubMed ID: 3090465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis.
    Cella SG; Locatelli V; De Gennaro V; Pellini C; Pintor C; Müller EE
    Endocrinology; 1986 Sep; 119(3):1164-70. PubMed ID: 3089765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin.
    Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D
    Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.
    Jeffery S; Carter ND; Clark RG; Robinson IC
    Biochem J; 1990 Feb; 266(1):69-74. PubMed ID: 1968744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GRF(1-40) and domperidone on GH secretion in normal man.
    Giusti M; Mazzocchi G; Sessarego P; Mignone D; Lomeo A; Monachesi M; Giordano G
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):339-43. PubMed ID: 6439434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
    Zanoboni A; Gibillini M; Cucchi MR; Zanoboni Muciaccia W; Zanussi C
    J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.